NELARABINE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62332-813 -
Package NDC
62332-813-50 -
Package NDC
62332-813-63 -
Application number
ANDA218554 -
SPL ID
3869e365-aa84-42e8-a307-e84be57588f7 -
SPL set ID
a2a08758-9a9d-49a2-a498-9da109045ee9 -
UNII
60158CV180 -
RxCUI
603566
What the source publishes
- Labeler
- Alembic Pharmaceuticals Inc.
- Active ingredients
- nelarabine
- Form
- INJECTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "NELARABINE",
"splId": "3869e365-aa84-42e8-a307-e84be57588f7",
"labels": [
{
"setId": "a2a08758-9a9d-49a2-a498-9da109045ee9",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a2a08758-9a9d-49a2-a498-9da109045ee9",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a2a08758-9a9d-49a2-a498-9da109045ee9"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Alembic Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL in 1 CARTON (62332-813-50) / 50 mL in 1 VIAL",
"package_ndc": "62332-813-50",
"identifierStatus": "well-formed",
"marketing_start_date": "20240801"
},
{
"sample": false,
"description": "6 VIAL in 1 CARTON (62332-813-63) / 50 mL in 1 VIAL",
"package_ndc": "62332-813-63",
"identifierStatus": "well-formed",
"marketing_start_date": "20240801"
}
],
"productId": "62332-813_3869e365-aa84-42e8-a307-e84be57588f7",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "62332-813",
"deaSchedule": null,
"genericName": "nelarabine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NELARABINE",
"strength": "5 mg/mL"
}
],
"applicationNumber": "ANDA218554",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240801",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000233",
"N0000175595"
],
"unii": [
"60158CV180"
],
"rxcui": [
"603566"
],
"spl_set_id": [
"a2a08758-9a9d-49a2-a498-9da109045ee9"
],
"pharm_class_epc": [
"Nucleoside Metabolic Inhibitor [EPC]"
],
"pharm_class_moa": [
"Nucleic Acid Synthesis Inhibitors [MoA]"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62332-813_3869e365-aa84-42e8-a307-e84be57588f7"